SCHEMBL7375052

SCHEMBL7375052

N#Cc1cccc(Cn2ccc(CN)n2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.50
CYP11B1 P15538 1/20 0.50
CYP11B2 P19099 1/20 0.50
ALDH1A1 P00352 2/20 0.46
L3MBTL1 Q9Y468 2/20 0.43
TDP1 Q9NUW8 1/20 0.43
CREBBP Q92793 1/20 0.42
KLKB1 P03952 1/20 0.39
KLK1 P06870 1/20 0.39
HRH3 Q9Y5N1 1/20 0.38
BRD4 O60885 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC7 Q8WUI4 1/20 0.38
ADRA1D P25100 1/20 0.38
LOXL2 Q9Y4K0 1/20 0.38
TGFBR1 P36897 2/20 0.37
ALK Q9UM73 1/20 0.37
KMT2A Q03164 1/20 0.37
SIRT2 Q8IXJ6 1/20 0.37
SIRT1 Q96EB6 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7374197 0.87 CYP19A1 (0.51) CYP19A1CYP11B1CYP11B2ALDH1A1L3MBTL1
SCHEMBL1065891 0.83 ALDH1A1 (0.62) CYP19A1CYP11B1CYP11B2ALDH1A1L3MBTL1
SCHEMBL7375050 0.77 ADRA1D (0.48) CYP19A1CYP11B1CYP11B2ALDH1A1L3MBTL1
SCHEMBL7369990 0.77 CYP19A1 (0.46) CYP19A1CYP11B1CYP11B2ALDH1A1L3MBTL1
SCHEMBL24991855 0.76 CYP19A1 (0.48) CYP19A1CYP11B1CYP11B2ALDH1A1CREBBP
SCHEMBL1068209 0.75 CYP19A1 (0.47) CYP19A1CYP11B1CYP11B2ALDH1A1L3MBTL1
SCHEMBL2699902 0.74 CYP19A1 (0.52) CYP19A1CYP11B1CYP11B2ALDH1A1L3MBTL1
SCHEMBL3920408 0.74 GRM5 (0.60) CYP19A1CYP11B1CYP11B2ALDH1A1TGFBR1
SCHEMBL25381660 0.74 ALDH1A1 (0.54) CYP19A1CYP11B1CYP11B2ALDH1A1CREBBP
SCHEMBL30561635 0.74 ALDH1A1 (0.54) CYP19A1CYP11B1CYP11B2ALDH1A1CREBBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002000651-A2 FACTOR XA INHIBITORS BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2002-01-03 WO disclosed